Clinical Research Directory
Browse clinical research sites, groups, and studies.
Observational Cross-reactivity Study for Colorectal Cancer Diagnosis
Sponsor: ADVANCED MARKER DISCOVERY S.L.
Summary
The objective of this observational study is to evaluate the false positive rate of the blood test based on molecular biomarkers and risk factors. A total of 250 patients diagnosed with various cancers and gastrointestinal diseases will be enrolled. The main question to be answered is Does the blood test have a low false positive rate in the main study population? Participants will donate a blood sample as part of their regular medical care for cancer diagnosis and give the consent to know their clinical risk factors.
Official title: Observational Cross-reactivity Study to Evaluate the Specificity of a Blood Test for Colorectal Cancer Diagnosis Based on Molecular Markers and Risk Factors Identified With Artificial Intelligence Tools
Key Details
Gender
All
Age Range
18 Years - Any
Study Type
OBSERVATIONAL
Enrollment
250
Start Date
2023-04-17
Completion Date
2025-12
Last Updated
2025-10-01
Healthy Volunteers
No
Conditions
Interventions
blood sampling
Patients will donate a blood sample for molecular analysis of molecular biomarkers in plasma, which being the only procedure in the study.
Locations (5)
Hospitales HM de Malaga
Málaga, Andalusia, Spain
Hospital Centro Médico Asturias
Oviedo, Cantabria, Spain
Hospital Universitario de Ourense
Ourense, Galicia, Spain
Hospital Universitario HM Sanchinarro
Madrid, Madrid, Spain
MD Anderson Cancer Centre
Madrid, Madrid, Spain